Skip to content
Longterm Wiki has not been actively maintained since May 2026. Some data is still updated occasionally, but please don't rely on this site being current or accurate.
Longterm Wiki
Index
Grant·5mv2MnKU_f·Record·Profile

Grant: ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing (Advanced Research and Invention Agency (ARIA) → University of Birmingham)

Verdictpartial75%
2 checks · 1 src · 9/21/2026

1 → partial; stale (excluded): 1 → partial

Our claim

entire record
Name
ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing
Currency
GBP
Date
September 2024
Notes
[Safeguarded AI TA3] Safeguarded AI-Enabled Biopharmaceutical Manufacturing. Lead(s): Mirco Giacobbe, Leonardo Stella, Paul Devine, Jared Delmar. Institutions: University of Birmingham / AstraZeneca. Status: active.

Source evidence

1 src · 2 checks
partial50%deterministic-row-match · 9/21/2026
Grantee
Hashberg Ltd / University of Birmingham
Focus Area
TA1.1
Name
Hyper-optimised Tensor Contraction for Neural Networks Verification
Description
Hashberg Ltd / University of Birmin

NotePartial deterministic match: grantee matched but name did not (48 rows)

partial75%Haiku 4.5 · 3/25/2026

NoteThe record claims a grant titled 'ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing' dated 2024-09. The source confirms TA3 exists within ARIA's Safeguarded AI programme, but contradicts the premise by stating the programme is NOT proceeding with TA3 Phase 2 and is pivoting focus. The source does not mention 'Biopharmaceutical Manufacturing' specifically as a TA3 focus. The specific identifiers (XqjV4mbMXQ, bEVAImWDe3) and exact date cannot be verified from the source. The record appears to reference a grant that may not have been awarded or may be outdated given the programme's stated pivot away from TA3.

Case № 5mv2MnKU_fFiled 9/21/2026Confidence 75%